|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
ocn587390006 |
| 003 |
OCoLC |
| 005 |
20240909213021.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
100330s2010 njua ob 001 0 eng d |
| 010 |
|
|
|z 2009040200
|
| 040 |
|
|
|a DG1
|b eng
|e pn
|c DG1
|d N$T
|d EBLCP
|d YDXCP
|d IDEBK
|d E7B
|d CDX
|d DG1
|d OCLCQ
|d MHW
|d OCLCQ
|d HNW
|d DKDLA
|d OCLCQ
|d OCLCO
|d OCLCF
|d OCLCA
|d OCLCQ
|d NLGGC
|d OCLCQ
|d COO
|d OCLCQ
|d DEBBG
|d AZK
|d LOA
|d OCLCO
|d OCLCA
|d COCUF
|d DG1
|d CHVBK
|d OCLCO
|d MOR
|d YDX
|d OCLCO
|d LIP
|d OCLCO
|d PIFAG
|d ZCU
|d OCLCO
|d OCLCQ
|d MERUC
|d OCLCO
|d OCLCQ
|d OCLCO
|d STF
|d OCLCO
|d OCLCA
|d U3W
|d OCLCA
|d OCLCQ
|d WRM
|d OCLCA
|d ICG
|d INT
|d NRAMU
|d VT2
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d WYU
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCO
|d DKC
|d OCLCQ
|d UX1
|d OCLCQ
|d OCLCA
|d UKCRE
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCL
|
| 016 |
7 |
|
|a 101516114
|2 DNLM
|
| 019 |
|
|
|a 607552736
|a 647902966
|a 748211962
|a 792934875
|a 816376983
|a 961553205
|a 962615165
|a 966232881
|a 988510432
|a 991915099
|a 1037937244
|a 1038697082
|a 1045528253
|a 1058357592
|a 1066566159
|a 1081265130
|a 1153464500
|a 1228556487
|
| 020 |
|
|
|a 9780470599686
|
| 020 |
|
|
|a 0470599685
|
| 020 |
|
|
|a 9780470599679
|q (electronic bk.)
|
| 020 |
|
|
|a 0470599677
|q (electronic bk.)
|
| 020 |
|
|
|a 0470247517
|q (cloth)
|
| 020 |
|
|
|a 9780470247518
|q (cloth)
|
| 020 |
|
|
|z 9780470247518
|q (cloth)
|
| 024 |
7 |
|
|a 10.1002/9780470599686
|2 doi
|
| 035 |
|
|
|a (OCoLC)587390006
|z (OCoLC)607552736
|z (OCoLC)647902966
|z (OCoLC)748211962
|z (OCoLC)792934875
|z (OCoLC)816376983
|z (OCoLC)961553205
|z (OCoLC)962615165
|z (OCoLC)966232881
|z (OCoLC)988510432
|z (OCoLC)991915099
|z (OCoLC)1037937244
|z (OCoLC)1038697082
|z (OCoLC)1045528253
|z (OCoLC)1058357592
|z (OCoLC)1066566159
|z (OCoLC)1081265130
|z (OCoLC)1153464500
|z (OCoLC)1228556487
|
| 037 |
|
|
|a 10.1002/9780470599686
|b Wiley InterScience
|n http://www3.interscience.wiley.com
|
| 050 |
|
4 |
|a RM301.25
|b .R67 2010
|
| 072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Rosenberg, Michael J.
|
| 245 |
1 |
4 |
|a The agile approach to adaptive research :
|b optimizing efficiency in clinical development /
|c Michael J. Rosenberg.
|
| 260 |
|
|
|a Hoboken, N.J. :
|b Wiley,
|c ©2010.
|
| 300 |
|
|
|a 1 online resource (xix, 274 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 380 |
|
|
|a Bibliography
|
| 490 |
1 |
|
|a Wiley series on technologies for the pharmaceutical industry
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Opportunity for efficiency -- Defining and extending the adaptive approach -- Design adaptations part one : finding the right dose -- Design adaptations part two : additional design changes -- Operational adaptations -- Agile clinical development -- Planning adaptive programs -- Statistics and decision making in adaptive research -- The agile platform -- The future of clinical development.
|
| 520 |
|
|
|a Apply adaptive research to improve results in drug development. The pharmaceutical industry today faces a deepening crisis: inefficiency in its core business, the development of new drugs. The Agile Approach to Adaptive Research offers a solution. It outlines how adaptive research, using already-available tools and techniques, can enable the industry to streamline clinical trials and reach decision points faster and more efficiently. With a wealth of real-world cases and examples, author Michael Rosenberg gives readers a practical overview of drug development, the problems inherent in current practices, and the advantages of adaptive research technology and methods. He explains the concepts, principles, and specific techniques of adaptive research, and demonstrates why it is an essential evolutionary step toward improving drug research and development. --From publisher's description.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
0 |
|a Pharmaceutical industry.
|
| 650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drug development
|2 fast
|
| 650 |
|
7 |
|a Pharmaceutical industry
|2 fast
|
| 758 |
|
|
|i has work:
|a The agile approach to adaptive research (Work)
|1 https://id.oclc.org/worldcat/entity/E39PCYJRc9J7yprYK8MbBckfmb
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Rosenberg, Michael J.
|t Agile approach to adaptive research.
|d Hoboken, N.J. : Wiley, ©2010
|z 9780470247518
|z 0470247517
|w (DLC) 2009040200
|w (OCoLC)444337872
|
| 830 |
|
0 |
|a Wiley series on technologies for the pharmaceutical industry.
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=487636
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|